- Home
- ACA vs RARE Comparison
ACA vs RARE Comparison
Compare ACA & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACA
- RARE
- Stock Information
- Founded
- ACA 2018
- RARE 2010
- Country
- ACA United States
- RARE United States
- Employees
- ACA N/A
- RARE N/A
- Industry
- ACA Metal Fabrications
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- ACA Industrials
- RARE Health Care
- Exchange
- ACA Nasdaq
- RARE Nasdaq
- Market Cap
- ACA 5.3B
- RARE 5.2B
- IPO Year
- ACA N/A
- RARE 2014
- Fundamental
- Price
- ACA $99.34
- RARE $43.98
- Analyst Decision
- ACA Strong Buy
- RARE Strong Buy
- Analyst Count
- ACA 4
- RARE 14
- Target Price
- ACA $104.25
- RARE $88.43
- AVG Volume (30 Days)
- ACA 264.0K
- RARE 717.6K
- Earning Date
- ACA 10-30-2024
- RARE 02-13-2025
- Dividend Yield
- ACA 0.20%
- RARE N/A
- EPS Growth
- ACA N/A
- RARE N/A
- EPS
- ACA 2.63
- RARE N/A
- Revenue
- ACA $2,485,900,000.00
- RARE $522,745,000.00
- Revenue This Year
- ACA $13.91
- RARE $27.36
- Revenue Next Year
- ACA $13.85
- RARE $18.61
- P/E Ratio
- ACA $37.78
- RARE N/A
- Revenue Growth
- ACA 11.68
- RARE 27.44
- 52 Week Low
- ACA $72.75
- RARE $37.02
- 52 Week High
- ACA $113.43
- RARE $60.37
- Technical
- Relative Strength Index (RSI)
- ACA 35.23
- RARE 33.50
- Support Level
- ACA $105.68
- RARE $41.45
- Resistance Level
- ACA $107.95
- RARE $50.00
- Average True Range (ATR)
- ACA 2.93
- RARE 1.83
- MACD
- ACA -1.47
- RARE -0.31
- Stochastic Oscillator
- ACA 17.48
- RARE 26.55
About ACA Arcosa Inc.
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.